Abstract
Cell surface glycoconjugates play an important role in cellular recognition and adhesion. Modification of these structures in tumour cells could affect tumour cell growth and behaviour, including metastasis. 2-Acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-α-D-glycopyranose (4-F-GlcNAc) was synthesized as a potential inhibitor and/or modifier of tumour cell glycoconjugates. The effect of this sugar analogue on the adhesive properties of human colon carcinoma HT-29 cells was evaluated. Treatment of HT-29 cells with 4-F-GlcNAc led to reduced cell surface expression of terminal lactosamine, sialyl-Lex and sialyl-Lea, as determined by Western blotting and flow cytometry. The aberrant expression of these oligosaccharide structures on the HT-29 cell surface resulted in: (1) decreased E-selectin mediated adhesion of human colon cells to human umbilical cord endothelial cells (HUVEC); (2) impaired adhesion of HT-29 cells to β-galactoside binding lectin, galectin-1; and (3) reduced ability to form homotypic aggregates. After exposure to 4-F-GlcNAc, lysosomal associated membrane proteins (lamp) 1 and 2, and carcinoembryonic antigen (CEA) detected in HT-29 cells were of lower molecular weight, probably due to impaired glycosylation. These results strongly suggest that modification of tumour cell surface molecules can alter tumour cell adhesion and that tumour cell surface oligosaccharides may be suitable targets for therapeutic exploitation.
Similar content being viewed by others
Abbreviations
- 4-F-GlcNAc:
-
2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-α-glucopyranose
- GlcNAc:
-
N-acetylglucosamine
- s-Lex :
-
sialyl-Lewisx
- s-Lea :
-
sialyl-Lewisa
- lamp-1 and lamp-2:
-
Lysosomal Associated Membrane Protein 1 and 2
- CEA:
-
carcinoembryonic antigen
- DMEM:
-
Dulbecco's Modified Eagle Medium
- PBS:
-
Phosphate Buffered Saline (2.7 mM KCl, 1.5 mM KH2PO4, 137 mM NaCl, 6.5 mM Na2HPO4, pH 7.3)
- BSA:
-
Bovine Serum Albumin
- PMSF:
-
Phenylmethylsulfonylfluoride
- TBS:
-
Tris Buffered Saline (10 mM Tris, 20 mM NaCl, pH 7.3)
- TCA:
-
Trichloroacetic Acid
- DSA:
-
Datura stramonium agglutinin
References
Hakamori S (1989)Adv Cancer Res 52: 257–331.
Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS (1991)J Clin Invest 87: 1037–45.
Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R (1991)Cancer Res 51: 387–93.
Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JM (1991)Cancer Res 51: 718–23.
Lauri D, Needham L, Martin-Padura I, Dejana E (1991)J Natl Cancer Inst 83: 1321–24.
Dejana E, Bertocchi F, Bortolami M, Regonesi A, Tonta A, Breviario F, Giavazzi R (1988)J Clin Invest 82: 1466–70.
Rice G, Gimbrone M, Bevilacqua M (1988)Am J Pathol 133: 204–20.
Lauri D, Bertomeu M, Orr F, Bastida E, Sauder D, Buchanan MR (1990)Clin Exp Metastasis 8: 27–32.
Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R (1989)Cell 59: 1203–11.
Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K, Hasewaga A, Kannagi R (1991)Biochem Biophys Res Comm 179: 713–19.
Saitoh O, Wang W-C, Lotan R, Fukuda M (1992)J Biol Chem 267: 5700–11.
Lippincott-Schwartz J, Fambrough DM (1987)Cell 49: 669–77.
Mane SM, Zarzella L, Bainton DF, Bainton DF, Holt VK, Cha Y, Hildreth JEK, August JT (1989)Arch Biochem Biophys 268: 360–78.
Carlsson SR, Fukuda M (1992)Arch Biochem Biophys 296: 630–39.
Skrincosky D, Allen HJ, Bernacki RJ (1993)Cancer Res 53: 2667–75.
Viitala J, Carlsson SR, Siebert PD, Fukuda M (1988)Proc Natl Acad Sci USA 85: 3743–47.
Carlsson SR, Roth J, Piller F, Fukuda M (1988)J Biol Chem 263: 18911–19.
Feizi T (1985)Nature 314: 53–57.
Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC (1984)J Biol Chem 259: 10925–35.
Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakamori SI (1984)Cancer Res 44: 5279–85.
Fukushi Y, Nudelman E, Levery SB, Hakamori S, Rauvala H (1984)J Biol Chem 259: 10511–17.
Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V (1982)J Biol Chem 257: 14365–69.
Kawakami H, Ito M, Miura Y, Hirano H (1994)Clin Exp Metastasis 12: 129–33.
Yuan M, Itzkowitz SH, Ferrell L, Fukushi Y, Palekar A, Hakamori SI, Kim YS (1987)J Natl Cancer Inst 78: 479–88.
Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakamori S, Irimura T (1989)Cancer Res 49: 6883–88.
Matushita Y, Cleary KR, Ota DM, Hoff SD, Irimura T (1990)Lab Invest 63: 780–91.
Matsushita Y, Nakamori S, Seftor E, Hendrix MJC, Irimura T (1991)Exp Cell Res 196: 20–25.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T (1993)Cancer Res 53: 3632–37.
Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners C (1989)Cell 57: 327–34.
Stanners C, Rojas M, Zhou H, Fuks A, Beauchemin N (1992)Int J Biol Markers 7: 137–42.
Jessup J, Thomas P (1989)Cancer Metastasis Rev 8: 263–80.
Turbide C, Rojas M, Stanners C, Beauchemin N (1991)J Biol Chem 266: 309–15.
Yamashita K, Totani K, Kuroki M, Matsuoka Y, Ueda I, Kobata A (1987)Cancer Res 47: 3451–59.
Chandrasekaran EV, Davila M, Nixon DW, Goldfarb M, Mendicino J (1983)J Biol Chem 258: 7213–22.
Wagner H, Toth C, Steele G, Thomas P (1992)Clin Exp Metastasis 10: 25–31.
Sharma M, Bernacki RJ, Paul B, Korytnyk W (1990)Carbohyd Res 198: 205–21.
Woynarowska B, Skrincosky DM, Haag A, Sharma M, Matta K, Bernacki RJ (1994)J Biol Chem 269: 22797–803.
Laemmli UK (1970)Nature 227: 680–85.
Schacterle GR, Pollack RL (1973)Anal Biochem 51: 654–55.
Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K-i, Leffler H, Liu F-T, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PW, Rini JM, Wang JL (1994)Cell 76: 597–98.
Ahmed H, Allen HJ, Sharma A, Matta KL (1990)Biochemistry 29: 5315–19.
Lee RT, Ichikawa Y, Allen HJ, Lee YC (1990)J Biol Chem 265: 7864–71.
Sawada R, Lowe JB, Fukuda M (1993)J Biol Chem 268: 12675–81.
Crowley JF, Goldstein IJ, Arnarp J, Lonngren J (1984)Arch Biochem Biophys 231: 524–33.
Lowe JB, Stoolman E, Oates JE, Dell A, Klock JC (1984)J Biol Chem 259: 10925–35.
Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakamori S, Paulson J (1990)Science 250: 1130–32.
Waltz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B (1990)Science 250: 1132–35.
Polley MJ, Phillips ML, Wayner E, Nudelman E, Singhal AK, Hakamori S, Paulson J (1991)Proc Natl Acad Sci USA 88: 6224–28.
Larsen E, Palabrica T, Sajer S, Gilbert GE, Wagner DD, Furie BC, Furie B (1990)Cell 63: 467–74.
Rice GE, Bevilacqua MP (1989)Science 246: 1303–6.
Hession C, Osborn L, Goff D, Chi-Rosso G, Vassallo L, Pasek M, Pittack C, Tizard R, Goelz S, McCarthy K, Hopple S, Lobb R (1989)Proc Natl Acad Sci USA 87: 1673–77.
Allen HJ, Sucato D, Woynarowska B, Gottstine S, Sharma A, Bernacki RJ (1990)J Cell Biochem 43: 43–57.
Ohannesian DW, Lotan D, Lotan R (1994)Cancer Res 54: 5992–6000.
Sawada R, Tsuboi S, Fukuda M (1994)J Biol Chem 269: 1425–31.
Martin-Padura I, Bazzoni G, Zanetti A, Bernasconi S, Elices MJ, Mantovani A, Dejana E (1994)J Biol Chem 269: 6124–32.
Huang J, Byrd JC, Yoon WH, Kim YS (1992)Oncol Res 4: 507–15.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woynarowska, B., Dimitroff, C.J., Sharma, M. et al. Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconjugate J 13, 663–674 (1996). https://doi.org/10.1007/BF00731455
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00731455